Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
J Cell Physiol ; 224(3): 817-26, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20578249

ABSTRACT

Mutations in cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia (MED). We studied the effects of over-expression of wild type and mutant COMP on early stages of chondrogenesis in chicken limb bud micromass cultures. Cells were transduced with RCAS virus harboring wild type or mutant (C328R, PSACH; T585R, MED) COMP cDNAs and cultured for 3, 4, and 5 days. The effect of COMP constructs on chondrogenesis was assessed by analyzing mRNA and protein expression of several COMP binding partners. Cell viability was assayed, and evaluation of apoptosis was performed by monitoring caspase 3 processing. Over-expression of COMP, and especially expression of COMP mutants, had a profound affect on the expression of syndecan 3 and tenascin C, early markers of chondrogenesis. Over-expression of COMP did not affect levels of type II collagen or matrilin-3; however, there were increases in type IX collagen expression and sulfated proteoglycan synthesis, particularly at day 5 of harvest. In contrast to cells over-expressing COMP, cells with mutant COMP showed reduction in type IX collagen expression and increased matrilin 3 expression. Finally, reduction in cell viability, and increased activity of caspase 3, at days 4 and 5, were observed in cultures expressing either wild type or mutant COMP. MED, and PSACH mutations, despite displaying phenotypic differences, demonstrated only subtle differences in their cellular viability and mRNA and protein expression of components of the extracellular matrix, including those that interact with COMP. These results suggest that COMP mutations, by disrupting normal interactions between COMP and its binding partners, significantly affect chondrogenesis.


Subject(s)
Achondroplasia/genetics , Cell Culture Techniques , Chondrogenesis/physiology , Extracellular Matrix Proteins/genetics , Glycoproteins/genetics , Limb Buds/physiology , Mutation , Osteochondrodysplasias/genetics , Achondroplasia/pathology , Amino Acid Sequence , Animals , Cartilage Oligomeric Matrix Protein , Cell Survival , Cells, Cultured , Chickens , Extracellular Matrix/metabolism , Extracellular Matrix Proteins/metabolism , Glycoproteins/metabolism , Humans , Limb Buds/cytology , Matrilin Proteins , Molecular Sequence Data , Osteochondrodysplasias/pathology , Sequence Alignment , Syndecans/genetics , Syndecans/metabolism , Tenascin/genetics , Tenascin/metabolism
2.
Ann N Y Acad Sci ; 961: 172-7, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12081893

ABSTRACT

Collagenase-treated, explanted human trabecular-bone chips are an excellent source of osteoblast-like cells. We have recently shown the multiple differentiation potential of these cells; in addition to osteogenesis and adipogenesis, these cells also undergo chondrogenesis when maintained as high-density pellet cultures (250,000 cells/pellet) in a serum-free, chemically defined medium stimulated with TGF-beta1 (10 ng/mL). In this investigation, we have analyzed how transactivating nuclear transcription factors, specifically AP-2 and SP-1, may interact with common cis-acting elements found in the regulatory region of cartilage-specific genes as part of the signal transduction mechanism of TGF-beta1 and p38 during chondrogenesis of human trabecular bone-derived multipotential cells. Both TGF-beta1 stimulation and p38 MAP kinase activation affect the binding of AP-2 as well as SP-1 to oligonucleotides with sequence similarity to the overlapping AP-2/SP-1 sites found in the putative 52-bp immediate upstream regulatory region and the 5'-untranslated region of the human aggrecan gene. Electrophoretic mobility shift assays show that TGF-beta1 treatment of the bone-derived cells inhibits AP-2 DNA binding but enhances the DNA binding ability of SP-1. Additionally, treatment of these TGF-beta1-stimulated cells with p38 MAP kinase inhibitor, SB203580, rescued the AP-2 DNA binding but did not affect SP-1 DNA binding. These findings indicate that AP-2 DNA binding is the target of both TGF-beta1 and p38 MAP kinase signaling pathways and suggest a possible signal transduction cascade whereby TGF-beta1 induction of chondrogenesis involves the activation of p38 MAP kinase and the subsequent inhibition of DNA binding by AP-2, thereby preventing the transcriptional repression of the aggrecan gene.


Subject(s)
Bone and Bones/metabolism , Chondrocytes/cytology , DNA-Binding Proteins/metabolism , Mitogen-Activated Protein Kinases/physiology , Transcription Factors/metabolism , Transforming Growth Factor beta/metabolism , Bone Development , Bone and Bones/cytology , Cell Differentiation , Cell Division , Cell Nucleus/metabolism , Enzyme Activation , Enzyme Inhibitors/pharmacology , Humans , Imidazoles/pharmacology , Mesoderm/cytology , Mitogen-Activated Protein Kinases/metabolism , Pyridines/pharmacology , RNA/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Sp1 Transcription Factor/metabolism , Transcription Factor AP-2 , Transforming Growth Factor beta1 , p38 Mitogen-Activated Protein Kinases
3.
J Cell Biochem ; 77(2): 252-64, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10723091

ABSTRACT

Cells of the baby hamster kidney (BHK) line express the skeletal muscle determining transcription factor MyoD but fail to differentiate. Unlike most skeletal myogenic cells, which express multiple members of the cadherin family of cell-cell adhesion proteins, the BHK cells lack a robust cadherin adhesion system. We previously published that forced expression of N- (or E)-cadherin in BHK cells increases the level of endogenous catenins, mediates strong cell-cell adhesion, and enhances differentiation of BHK cells induced to differentiate by placing them in three-dimensional (3-D) culture (Redfield et al. [1997] J. Cell. Biol. 138:1323-1331). This report demonstrates that N-cadherin adhesion upregulates the protein level of nuclear myogenin in cells induced to differentiate by 3-D culture. Myogenin is a transcription factor required for differentiation of skeletal muscle. It was not detected in monolayer culture, whether the cells expressed N-cadherin or not, nor was it upregulated in 3-D cultures of cells lacking N-cadherin. The activity of two myogenin-chloramphenicol acetyltransferase (CAT) reporter constructs containing 3.7 or 1.1 kb upstream regulatory region of the mouse myogenin gene was increased significantly in N-cadherin-expressing cells induced to differentiate by 3-D culture. Our observations indicate that N-cadherin adhesion stimulates skeletal myogenesis by upregulating myogenin.


Subject(s)
Cadherins/metabolism , Muscle, Skeletal/cytology , Muscle, Skeletal/metabolism , Myogenin/metabolism , Trans-Activators , Animals , Cadherins/genetics , Cell Adhesion , Cell Differentiation , Cell Line , Chloramphenicol O-Acetyltransferase/genetics , Cricetinae , Cytoskeletal Proteins/metabolism , Genes, Reporter , Mice , Myogenin/genetics , Signal Transduction , Up-Regulation , beta Catenin
4.
Dev Biol ; 184(2): 343-50, 1997 Apr 15.
Article in English | MEDLINE | ID: mdl-9133440

ABSTRACT

The outgrowth of the mesoderm of the developing limb bud in response to the apical ectodermal ridge (AER) is mediated at least in part by members of the FGF family. Recent studies have indicated that FGFs need to interact with heparan sulfate proteoglycans in order to bind to and activate their specific cell surface receptors. Syndecan-3 is an integral membrane heparan sulfate proteoglycan that is highly expressed by the distal mesodermal cells of the chick limb bud that are undergoing proliferation and outgrowth in response to the AER. Here we report that maintenance of high-level syndecan-3 expression by the subridge mesoderm of the chick limb bud is directly or indirectly dependent on the AER, since its expression is severely impaired in the distal mesoderm of the limb buds of limbless and wingless mutant embryos which lack functional AERs capable of directing the outgrowth of limb mesoderm. We have also found that exogenous FGF-2 maintains a domain of high-level syndecan-3 expression in the outgrowing mesodermal cells of explants of the posterior mesoderm of normal limb buds cultured in the absence of the AER and in the outgrowing subapical mesoderm of explants of limbless mutant limb buds which lack a functional AER. These results suggest that the domain of high-level syndecan-3 expression in the subridge mesoderm of normal limb buds is maintained by FGFs produced by the AER. Finally, we report that polyclonal antibodies against a syndecan-3 fusion protein inhibit the ability of FGF-2 to promote the proliferation and outgrowth of the posterior subridge mesoderm of limb buds cultured in the absence of the AER. These results suggest that syndecan-3 plays an essential role in limb outgrowth by mediating the interaction of FGFs produced by the AER with the underlying mesoderm of the limb bud.


Subject(s)
Fibroblast Growth Factor 2/pharmacology , Membrane Glycoproteins/metabolism , Mesoderm/cytology , Proteoglycans/metabolism , Receptors, Fibroblast Growth Factor/metabolism , Animals , Antibodies/immunology , Cell Division/drug effects , Chick Embryo , DNA Probes , Ectoderm/physiology , Gene Expression Regulation, Developmental , Immunohistochemistry , In Situ Hybridization , Limb Buds , Mesoderm/drug effects , Mesoderm/metabolism , Mutation/genetics , Organ Culture Techniques , RNA, Messenger/metabolism , Syndecan-3 , Transcription, Genetic
5.
Dev Dyn ; 207(1): 114-9, 1996 Sep.
Article in English | MEDLINE | ID: mdl-8875081

ABSTRACT

The transmembrane heparan sulfate proteoglycan syndecan-3 is transiently expressed in high amounts during the cellular condensation process that characterizes the onset of limb cartilage differentiation. During condensation, limb mesenchymal cells become closely juxtaposed and undergo cell-cell and cell-matrix interactions that are necessary to trigger cartilage differentiation and cartilage-specific gene expression. To test directly the possible involvement of syndecan-3 in regulating the onset of limb chondrogenesis, we examined the effect of polyclonal antibodies against a syndecan-3 fusion protein on the chondrogenic differentiation of chick limb mesenchymal cells in micromass culture. Syndecan-3 antiserum elicits a dose-dependent inhibition of the accumulation of Alcian blue-stainable cartilage matrix by high density limb mesenchymal cell micromass cultures (2 x 10(5) cells/10 microliters) and a corresponding reduction in steady-state levels of mRNAs for cartilage-characteristic type II collagen and the core protein of the cartilage proteoglycan aggrecan. In preimmune serum-treated control cultures proliferating cells are limited to the periphery of areas of cartilage matrix deposition, whereas large numbers of proliferating cells are uniformly distributed throughout the undifferentiated cultures supplemented with syndecan-3 antiserum. Limb mesenchymal cells cultured at lower densities (1 x 10(5) cells/10 microliters) in the presence of preimmune serum form extensive precartilage condensations characterized by the close juxtaposition of rounded cells by day 2 of culture. In contrast, in the presence of syndecan-3 antiserum, the cells fail to aggregate but rather remain flattened and spatially separated from one another, suggeting that syndecan-3 antibodies impair the formation of precartilage condensations. These results indicate that syndecan-3 plays an important role in regulating the onset of limb chondrogenesis, perhaps by mediating the cell-cell and cell-matrix interactions required for condensation and subsequent cartilage differentiation.


Subject(s)
Antibodies/pharmacology , Cartilage/cytology , Extracellular Matrix Proteins , Extremities/embryology , Membrane Glycoproteins/immunology , Proteoglycans/immunology , Receptors, Fibroblast Growth Factor/immunology , Aggrecans , Animals , Cell Differentiation/drug effects , Chick Embryo , Collagen/genetics , Lectins, C-Type , Proteoglycans/genetics , RNA, Messenger/metabolism , Syndecan-3
6.
Matrix Biol ; 14(9): 753-64, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8785590

ABSTRACT

To investigate the regulation of type II collagen gene expression in cells undergoing chondrogenic differentiation, we have employed a 5-kbp genomic fragment of the human type II collagen gene which contains 1.8kbp of upstream sequences, the transcription start site, the first exon and 3 kbp of intronic sequences, fused to either lac Z or chloramphenicol acetyl transferase-reporter gene. Transient expression studies revealed a parallel increase in transgene activity and endogenous type II collagen mRNA levels during the onset of the cartilage differentiation of limb mesenchymal cells in high-density micromass cultures. At later periods in culture, however, the transgene activity declines, although steady-state levels of type II collagen mRNA are reported to continue to increase (Kosher et al.: J. Cell. Biol. 102: 1151-1156, 1986; Kravis and Upholt. Dev. Biol. 108: 164-172, 1985). In addition, the activity of the transgene is seven-fold higher at the onset of chondrogenic differentiation in micromass cultures that in well differentiated sternal chondrocytes, although similar levels of type II collagen transcripts are found in these cells. Furthermore, deletions of intronic segments resulted in greater drop in activity of the constructs in differentiating chondrocytes in micromass cultures than in mature sternal chondrocytes. The expression of the construct in transgenic mice is higher at the onset of chondrogenic differentiation and in newly differentiated chondrocytes than in more mature differentiated chondrocytes. Based on these observations, it appears that the mechanisms involved in the regulation of the type II collagen gene at the onset of chondrocyte differentiation are different from those resulting in the maintenance of its expression in fully differentiated chondrocytes.


Subject(s)
Cartilage/cytology , Collagen/genetics , Gene Expression Regulation, Developmental , Animals , Cartilage/embryology , Cartilage/metabolism , Cell Differentiation , Cells, Cultured , Chick Embryo , Collagen/biosynthesis , Collagen/classification , Extremities/embryology , Genes, Reporter , Humans , Introns/genetics , Mesoderm/cytology , Mice , Mice, Transgenic , Organ Culture Techniques , Promoter Regions, Genetic , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/genetics , Sequence Deletion , Species Specificity , Sternum/cytology , Sternum/embryology , Transfection
7.
J Gen Virol ; 71 ( Pt 12): 2941-52, 1990 Dec.
Article in English | MEDLINE | ID: mdl-2177086

ABSTRACT

Herpes simplex virus type 1 (HSV-1) encodes a novel enzyme activity, the alkaline nuclease, whose precise role in the viral replication cycle remains obscure. The alkaline nuclease gene corresponds to the UL12 open reading frame, which is predicted to encode a protein of 626 amino acid residues. We describe the isolation and characterization of a null mutant of the gene for the viral alkaline nuclease in which 917 bp from the N-terminal half of the gene (corresponding to residues 70 to 375) were deleted and replaced by the insertional mutagen ICP6::lacZ. The resulting mutant virus, AN-1, was propagated in helper cells (S22) which express the wild-type version of the alkaline nuclease gene. Mutant AN-1 growth in Vero cells is severely restricted, although small amounts of infectious virus are produced. On the other hand, wild-type levels of viral DNA and late viral proteins are expressed in virus AN-1-infected Vero cells. These results indicate that the HSV-1 alkaline nuclease gene product is not essential for viral DNA synthesis but may play a role in the processing or packaging of viral DNA into infectious virions. Possible roles in the viral infectious cycle will be discussed.


Subject(s)
DNA Replication , DNA, Viral/genetics , Mutagenesis, Insertional , Ribonucleases/genetics , Simplexvirus/genetics , Animals , Genes, Viral , Molecular Weight , Plasmids , Restriction Mapping , Ribonucleases/metabolism , Simplexvirus/enzymology , Vero Cells , Viral Plaque Assay , Viral Proteins/biosynthesis , Viral Proteins/genetics , Viral Proteins/isolation & purification , Viral Structural Proteins/genetics , beta-Galactosidase/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...